SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation? Deetew's original link to article Here's hoping the NIH, CDC and FDA listen to this, swallow their pharma pride, and help Americans. They should publish a list of few known quality and safe products immediately available on the market , but foremost should be CVSI, as they have SA-GRAS. Heck, they should site only companies who have achieved SA-GRAS - it will be a very, very short list.
News 
Market Data 
Discover 
AI
